Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP125 vs bevacizumab for center-involved diabetic macular edema
TCTR20220517002Phase 4Unknown
- Sponsor
- Rajavithi Hospital
- Start
- Jun 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in diabetic macular edema (DME), sponsored by Rajavithi Hospital. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on TCTR20220517002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220517002.